Case number 3:24-cv-04264
INTRA-CELLULAR THERAPIES, INC. v. AUROBINDO PHARMA LTD. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 2, 2024 | 18 | NOTICE of Appearance by KATELYN O'REILLY on behalf of INTRA-CELLULAR THERAPIES, INC. (O'REILLY, KATELYN) (Entered: 07/02/2024) (1) |
| Jul 2, 2024 | 19 | NOTICE of Appearance by LAUREN RUTH MALAKOFF on behalf of INTRA-CELLULAR THERAPIES, INC. (MALAKOFF, LAUREN) (Entered: 07/02/2024) (1) |
| Jul 1, 2024 | 17 | ANSWER to Counterclaim by INTRA-CELLULAR THERAPIES, INC..(WALSH, LIZA) (Entered: 07/01/2024) (17) |
| Jun 14, 2024 | 16 | TEXT ORDER: The Court is in receipt of plaintiff's 6/12/24 letter (Dkt. 15 ) requesting the adjournment of the telephone status conference and Rule 16 conference. Provided that all parties agree (as the letter suggests) (i) to the consolidation/coordination of these cases for pretrial purposes, and (ii) to the submission of a single proposed joint discovery plan, no telephone status conference is necessary. The Rule 16 conference is rescheduled to 7/29/2024 at 10:00 a.m. in Trenton - Courtroom 7E. The parties shall submit a single proposed joint discovery plan no later than 7/15/2024. So Ordered by Magistrate Judge J. Brendan Day on 6/14/2024. (cry) (Entered: 06/14/2024) (0) |
| Jun 12, 2024 | 15 | Letter from Liza M. Walsh re 11 Order,,,, Set Hearings,,, 12 Order, Set Hearings, Set/Clear Flags. (WALSH, LIZA) (Entered: 06/12/2024) (2) |
| Jun 10, 2024 | 13 | Defendants' ANSWER to Complaint for Patent Infringement and, COUNTERCLAIM against INTRA-CELLULAR THERAPIES, INC. by All Defendants.(VARUGHESE, DENNIES) (Entered: 06/10/2024) (30) |
| Jun 10, 2024 | 14 | Corporate Disclosure Statement by AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA, INC. identifying Aurobindo Pharma Ltd. as Corporate Parent.. (VARUGHESE, DENNIES) (Entered: 06/10/2024) (3) |
| Jun 7, 2024 | 11 | TEXT ORDER: Please be advised that the Court will hold a joint Rule 16 scheduling conference in all six related cases (24-4312, 4314, 4317, 4264, 4325 and 4327) on July 8, 2024 at 3:30 p.m. A formal order scheduling the conference will be entered shortly. Before the Rule 16 conference, the Court will hold a joint telephone conference with counsel on 6/17/2024 at 3:00 p.m.; dial-in information will be provided. Counsel shall be prepared to discuss during the call the coordination of discovery and scheduling across the related cases. Please note that the Court at this time anticipates the submission of a single proposed joint discovery plan across the related cases in advance of the Rule 16 conference. So Ordered by Magistrate Judge J. Brendan Day on 6/7/2024. (cry) (Entered: 06/07/2024) (0) |
| Jun 7, 2024 | 12 | ORDER SCHEDULING CONFERENCE: Scheduling Conference set for 7/8/2024 at 3:30 PM in Trenton - Courtroom 7E before Magistrate Judge J. Brendan Day. Signed by Magistrate Judge J. Brendan Day on 6/7/2024. (jal, ) (Entered: 06/07/2024) (5) |
| Jun 3, 2024 | 10 | STIPULATION AND ORDER Extending Defendant's time to answer. move or otherwise respond to Plaintiff's Complaint through and including 6/10/2024. Signed by Magistrate Judge J. Brendan Day on 6/3/2024. (amv) (Entered: 06/03/2024) (2) |
| May 31, 2024 | 8 | NOTICE of Appearance by DENNIES VARUGHESE on behalf of All Defendants (VARUGHESE, DENNIES) (Entered: 05/31/2024) (2) |
| May 31, 2024 | 9 | Letter from Dennies Varughese to the Honorable J. Brendan Day, U.S.M.J.. (Attachments: # 1 Text of Proposed Order and Stipulation)(VARUGHESE, DENNIES) (Entered: 05/31/2024) (0) |
| Apr 11, 2024 | 6 | WAIVER OF SERVICE Returned Executed by INTRA-CELLULAR THERAPIES, INC.. AUROBINDO PHARMA LTD. waiver sent on 4/2/2024, answer due 6/3/2024. (WALSH, LIZA) (Entered: 04/11/2024) (1) |
| Apr 11, 2024 | 7 | WAIVER OF SERVICE Returned Executed by INTRA-CELLULAR THERAPIES, INC.. AUROBINDO PHARMA USA, INC. waiver sent on 4/2/2024, answer due 6/3/2024. (WALSH, LIZA) (Entered: 04/11/2024) (1) |
| Mar 29, 2024 | 5 | Corporate Disclosure Statement by INTRA-CELLULAR THERAPIES, INC.. (WALSH, LIZA) (Entered: 03/29/2024) (2) |
| Mar 28, 2024 | 2 | AO120 Patent/Trademark Form filed. (kht) (Entered: 03/28/2024) (1) |
| Mar 28, 2024 | 3 | AO120 Patent/Trademark Form filed. (kht) (Entered: 03/28/2024) (1) |
| Mar 28, 2024 | 4 | SUMMONS ISSUED as to AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA, INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (kht) (Entered: 03/28/2024) (2) |
| Mar 27, 2024 | 1 | COMPLAINT against AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA, INC. ( Filing and Admin fee $ 405 receipt number ANJDC-15219181), filed by INTRA-CELLULAR THERAPIES, INC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Civil Cover Sheet, # 10 AO 120 form 1, # 11 AO 120 form 2)(jr) (Entered: 03/27/2024) (0) |
| Mar 27, 2024 | N/A | Magistrate Judge J. Brendan Day added. (kht) (Entered: 03/28/2024) (0) |
